Frontiers in Public Health (Apr 2023)

Lag-time effects of vaccination on SARS-CoV-2 dynamics in German hospitals and intensive-care units

  • Bruno Enagnon Lokonon,
  • Bruno Enagnon Lokonon,
  • Yvette Montcho,
  • Yvette Montcho,
  • Paul Klingler,
  • Chénangnon Frédéric Tovissodé,
  • Romain Glèlè Kakaï,
  • Martin Wolkewitz

DOI
https://doi.org/10.3389/fpubh.2023.1085991
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundThe Efficacy and effectiveness of vaccination against SARS-CoV-2 have clearly been shown by randomized trials and observational studies. Despite these successes on the individual level, vaccination of the population is essential to relieving hospitals and intensive care units. In this context, understanding the effects of vaccination and its lag-time on the population-level dynamics becomes necessary to adapt the vaccination campaigns and prepare for future pandemics.MethodsThis work applied a quasi-Poisson regression with a distributed lag linear model on German data from a scientific data platform to quantify the effects of vaccination and its lag times on the number of hospital and intensive care patients, adjusting for the influences of non-pharmaceutical interventions and their time trends. We separately evaluated the effects of the first, second and third doses administered in Germany.ResultsThe results revealed a decrease in the number of hospital and intensive care patients for high vaccine coverage. The vaccination provides a significant protective effect when at least approximately 40% of people are vaccinated, whatever the dose considered. We also found a time-delayed effect of the vaccination. Indeed, the effect on the number of hospital patients is immediate for the first and second doses while for the third dose about 15 days are necessary to have a strong protective effect. Concerning the effect on the number of intensive care patients, a significant protective response was obtained after a lag time of about 15–20 days for the three doses. However, complex time trends, e.g. due to new variants, which are independent of vaccination make the detection of these findings challenging.ConclusionOur results provide additional information about the protective effects of vaccines against SARS-CoV-2; they are in line with previous findings and complement the individual-level evidence of clinical trials. Findings from this work could help public health authorities efficiently direct their actions against SARS-CoV-2 and be well-prepared for future pandemics.

Keywords